ASLAN Pharmaceuticals (ASLN) Short Interest Ratio & Short Volume → Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (From Priority Gold) (Ad) Free ASLN Stock Alerts $0.42 -0.03 (-7.30%) (As of 04/26/2024 08:52 PM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestSocial Media ASLAN Pharmaceuticals Short Interest DataCurrent Short Volume250,200 sharesPrevious Short Volume116,800 sharesChange Vs. Previous Month+114.21%Dollar Volume Sold Short$126,426.06Short Interest Ratio / Days to Cover0.2Last Record DateApril 15, 2024Outstanding Shares16,350,000 sharesFloat Size16,990,000 sharesShort Percent of Float1.47%Today's Trading Volume645,300 sharesAverage Trading Volume989,195 sharesToday's Volume Vs. Average65% Short Selling ASLAN Pharmaceuticals ? Sign up to receive the latest short interest report for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatASLN Short Interest Over TimeASLN Days to Cover Over TimeASLN Percentage of Float Shorted Over Time Ad DTIMy top 100 stocks…We recently ran an internal audit of every trade recommendation I’ve published across all my services… And let me tell ya, we found some incredible insights… For starters, we found about 100 stocks I trade really, really well.Get some cool freebies right here. ASLAN Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024250,200 shares $126,426.06 +114.2%1.5%0.2 $0.51 3/31/2024116,800 shares $71,855.36 -59.8%0.7%0.1 $0.62 3/15/2024290,500 shares $188,825.00 +1,405.2%1.8%0.3 $0.65 2/29/202419,300 shares $16,984.00 -38.3%0.1%0 $0.88 2/15/202431,300 shares $17,625.03 -46.7%0.2%0.1 $0.56 1/31/202458,700 shares $40,062.75 +9.3%0.4%0.3 $0.68 Get the Latest News and Ratings for ASLN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for ASLAN Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 1/15/202453,700 shares $50,773.35 -24.4%0.3%0.3 $0.95 12/31/202371,000 shares $37,069.10 +203.4%0.4%0.5 $0.52 12/15/202323,400 shares $13,525.20 -31.4%0.2%0.2 $0.58 11/30/202334,100 shares $23,535.82 -19.2%0.2%0.6 $0.69 11/15/202342,200 shares $43,044.00 +20.9%0.3%1.3 $1.02 10/31/202334,900 shares $38,390.00 +3.6%0.3%1.4 $1.10 10/15/202333,700 shares $43,136.00 -32.2%0.2%1.3 $1.28 9/30/202349,700 shares $93,436.00 -78.3%0.4%1.4 $1.88 9/15/2023228,600 shares $448,056.00 -6.5%1.7%2.2 $1.96 8/31/2023244,500 shares $519,562.50 -20.9%1.8%2 $2.13 8/15/2023308,900 shares $651,779.00 -6.9%2.2%2.2 $2.11 7/31/2023331,600 shares $782,576.00 0.0%2.6%2.2 $2.36 7/15/2023331,700 shares $932,077.00 +203.8%2.6%2.2 $2.81 6/30/2023109,200 shares $398,580.00 +105.3%1.0%0.8 $3.65 6/15/202353,200 shares $212,268.00 +25.2%0.5%0.7 $3.99 5/31/202342,500 shares $170,000.00 -91.2%0.4%0.8 $4.00 5/15/2023483,800 shares $2.10 million +16.5%4.2%9.6 $4.35 4/30/2023415,400 shares $1.72 million +1.7%3.1%10.4 $4.15 4/15/2023408,300 shares $1.44 million +3.7%3.0%10.4 $3.53 3/31/2023393,700 shares $1.13 million +1.0%2.9%10.8 $2.88 3/15/2023389,900 shares $1.25 million -79.9%2.9%9.5 $3.20 2/28/20231,940,000 shares $1.46 million +1.0%2.9%10.9 $0.76 2/15/20231,920,000 shares $1.52 million -1.0%2.9%10.9 $0.79 1/31/20231,940,000 shares $1.33 million +3.2%2.9%11.2 $0.69 1/15/20231,880,000 shares $1.20 million No Change2.8%8.1 $0.64 12/30/20221,880,000 shares $676,800.00 -0.5%2.8%8.5 $0.36 12/15/20221,890,000 shares $869,400.00 No Change2.8%9.9 $0.46 11/30/20221,890,000 shares $1.04 million -3.6%2.8%9.9 $0.55 11/15/20221,960,000 shares $975,296.00 -1.0%2.9%9.5 $0.50 10/31/20221,980,000 shares $799,920.00 +3.7%3.0%8.6 $0.40 10/15/20221,910,000 shares $957,101.00 -3.1%2.9%12 $0.50 9/30/20221,970,000 shares $1.18 million +2.1%2.9%12.7 $0.60 9/15/20221,930,000 shares $1.45 million +4.9%2.9%11.1 $0.75 8/31/20221,840,000 shares $1.14 million +0.6%2.8%8.4 $0.62The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide. ASLN Short Interest - Frequently Asked Questions What is ASLAN Pharmaceuticals' current short interest? Short interest is the volume of ASLAN Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 15th, traders have sold 250,200 shares of ASLN short. 1.47% of ASLAN Pharmaceuticals' shares are currently sold short. Learn More on ASLAN Pharmaceuticals' current short interest. Which institutional investors are shorting ASLAN Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of ASLAN Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for ASLAN Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.47% of ASLAN Pharmaceuticals' floating shares are currently sold short. Is ASLAN Pharmaceuticals' short interest increasing or decreasing? ASLAN Pharmaceuticals saw a increase in short interest during the month of April. As of April 15th, there was short interest totaling 250,200 shares, an increase of 114.2% from the previous total of 116,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is ASLAN Pharmaceuticals' float size? ASLAN Pharmaceuticals currently has issued a total of 16,350,000 shares. Some of ASLAN Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. ASLAN Pharmaceuticals currently has a public float of 16,990,000 shares. How does ASLAN Pharmaceuticals' short interest compare to its competitors? 1.47% of ASLAN Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to ASLAN Pharmaceuticals: Biofrontera Inc. (1.20%), TFF Pharmaceuticals, Inc. (2.77%), Lixte Biotechnology Holdings, Inc. (4.59%), Bionomics Limited (2.03%), Chemomab Therapeutics Ltd. (1.31%), Pasithea Therapeutics Corp. (1.34%), Kineta, Inc. (1.23%), Hepion Pharmaceuticals, Inc. (1.19%), eFFECTOR Therapeutics, Inc. (7.16%), Trevena, Inc. (0.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short ASLAN Pharmaceuticals stock? Short selling ASLN is an investing strategy that aims to generate trading profit from ASLAN Pharmaceuticals as its price is falling. ASLN shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against ASLAN Pharmaceuticals? A short squeeze for ASLAN Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ASLN, which in turn drives the price of the stock up even further. How often is ASLAN Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ASLN, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Biofrontera Short Interest TFF Pharmaceuticals Short Interest Lixte Biotechnology Short Interest Bionomics Short Interest Chemomab Therapeutics Short Interest Pasithea Therapeutics Short Interest Kineta Short Interest Hepion Pharmaceuticals Short Interest eFFECTOR Therapeutics Short Interest Trevena Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ASLN) was last updated on 4/29/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldAI finds its first serious applicationWall Street StarHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupHis win rate puts Warren Buffett to shame… Investing DailyTrump is sounding the alarmPreserve Gold